Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

109.81 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 109.81
Bid (Size) 109.02 (1)
Ask (Size) 110.64 (1)
Prev. Close 109.81
Today's Range 109.81 - 109.81
52wk Range 93.25 - 130.94
Shares Outstanding 1,750,942,289
Dividend Yield 1.64%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%. 
Via Talk Markets
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
At least four Wall Street banks recently raised their price targets for the healthcare giant. 
Via The Motley Fool

Performance

YTD
+0.21%
+0.21%
1 Month
+0.21%
+0.21%
3 Month
+10.99%
+10.99%
6 Month
+0.26%
+0.26%
1 Year
-13.85%
-13.85%

More News

Read More
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
Via Investor's Business Daily
What 5 Analyst Ratings Have To Say About Abbott Laboratories
Via Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Via Benzinga
What's Going On With Abbott Laboratories Stock Today?
Via Benzinga
Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth
Via Investor's Business Daily
NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Abbott's Sales and Earnings Are Sinking: Should Investors Worry?
Via The Motley Fool
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Via MarketBeat
Topics Economy
Exposures Interest Rates
Why Abbott Laboratories Stock Got Whacked on Wednesday
Via The Motley Fool
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
Via The Motley Fool
A Bullish Sign Appears On Abbott Laboratories's Chart
Via Benzinga
Earnings Outlook For Abbott Laboratories
Via Benzinga
Why Aurora Cannabis Stock Is Fading Today
Via The Motley Fool
Abbott Q4 Earnings And Revenues Top Estimates
Via Talk Markets
Microsoft's Gloomy Guidance, Boeing's Surprise Q4 Loss Pulls Market Lower
Via Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
Via Benzinga
Earnings Scheduled For January 25, 2023
Via Benzinga
Investor Optimism Declines Following Earnings Reports
Via Benzinga
Abbott Laboratories, QUALCOMM, GE HealthCare Technologies And This Subsidiary Of Diamondback Energy On CNBC's 'Final Trades'
Via Benzinga
Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk
Via Benzinga
Spotify To Downsize Employee Count, Activist Investor Elliott Invests Multibillion Dollars In Salesforce, Abbott Draws DOJ Investigation On Baby Formula Plant Shutdown: Today's Top Stories
Via Benzinga
Want Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023
Via The Motley Fool
6 Dividend Growth Stocks
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.